REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
58,417,175
Share change
+978,387
Total reported value
$7,219,796,205
Put/Call ratio
864%
Price per share
$124.38
Number of holders
442
Value change
+$74,553,209
Number of buys
199
Number of sells
241

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2025

As of 30 Jun 2025, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 442 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,417,175 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., VANGUARD GROUP INC, Point72 Asset Management, L.P., STATE STREET CORP, FMR LLC, Champlain Investment Partners, LLC, Invesco Ltd., Bank of New York Mellon Corp, and SANDS CAPITAL MANAGEMENT, LLC. This page lists 442 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.